SCM
Suvretta Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Buy |
11,535,582
+112,604
| +1% | +$1.58M | 4.88% | 1 |
|
|
2025
Q1 | $179M | Buy |
11,422,978
+23,840
| +0.2% | +$373K | 6.63% | 1 |
|
|
2024
Q4 | $159M | Buy |
11,399,138
+677,627
| +6% | +$9.44M | 5.41% | 2 |
|
|
2024
Q3 | $99.7M | Buy |
10,721,511
+717,019
| +7% | +$6.67M | 3.19% | 5 |
|
|
2024
Q2 | $93M | Buy |
10,004,492
+2,127,195
| +27% | +$19.8M | 3.42% | 5 |
|
|
2024
Q1 | $78.1M | Sell |
7,877,297
-595,804
| -7% | -$5.9M | 2.9% | 6 |
|
|
2023
Q4 | $27.4M | Buy |
8,473,101
+7,337,874
| +646% | +$23.7M | 1.24% | 28 |
|
|
2023
Q3 | $6.03M | Buy |
1,135,227
+262,800
| +30% | +$1.4M | 0.33% | 51 |
|
|
2023
Q2 | $8.31M | Buy |
872,427
+193,036
| +28% | +$1.84M | 0.44% | 53 |
|
|
2023
Q1 | $7.47M | Buy |
+679,391
| New | +$7.47M | 0.32% | 52 |
|